Clorox to Acquire GOJO Industries for $2.25 Billion

Reuters
Jan 23
Clorox to Acquire GOJO Industries for $2.25 Billion

The Clorox Company has entered into a definitive agreement to acquire GOJO Industries, the maker of Purell and a leader in skin health and hygiene solutions, for $2.25 billion in cash. The net purchase price is estimated at $1.92 billion after anticipated tax benefits of approximately $330 million. Clorox plans to fund the transaction primarily through debt financing and expects to complete the deal before the end of its fiscal year 2026, pending regulatory approval and customary closing conditions. The addition of Purell is expected to expand Clorox’s presence in health and hygiene for both consumers and institutional customers, advancing its strategy to deliver more consistent, profitable growth. Clorox reaffirmed its fiscal year 2026 outlook for net sales and earnings, excluding the impact of the transaction, and stated that integration plans remain on track.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Clorox Company published the original content used to generate this news brief via PR Newswire (Ref. ID: SF69238) on January 22, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10